ArticleComputational and mathematical methods in medicine2022
Supervised Computer-Aided Diagnosis (CAD) Methods for Classifying Alzheimer's Disease-Based Neurodegenerative Disorders.
Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 15 citations in OpenAlex.
- Retracted: Supervised Computer-Aided Diagnosis (CAD) Methods for Classifying Alzheimer's Disease-Based Neurodegenerative Disorders.Computational and mathematical methods in medicine · 2023Article
- An MRI Scans-Based Alzheimer's Disease Detection via Convolutional Neural Network and Transfer Learning.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
- Retraction · 2023-12-13Compromised Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Unreliable Results and/or Conclusions · · Name of author 2 and 6 derived from their Scopus profile
- Retracted
Authors and funding
6 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease is incurable at the moment. If it can be appropriately diagnosed, the correct treatment can postpone the patient's illness. To aid in the diagnosis of Alzheimer's disease and to minimize the time and expense associated with manual diagnosis, a machine learning technique is employed, and a transfer learning method based on 3D MRI data is proposed. Machine learning algorithms can dramatically reduce the time and effort required for human treatment of Alzheimer's disease. This approach extracts bottleneck features from the M-Net migration network and then adds a top layer to supervised training to further decrease the dimensionality and delete portions. As a consequence, the transfer network presented in this study has several advantages in terms of computational efficiency and training time savings when used as a machine learning approach for AD-assisted diagnosis. Finally, the properties of all subject slices are combined and trained in the classification layer, completing the categorization of Alzheimer's disease symptoms and standard control. The results show that this strategy has a 1.5 percentage point better classification accuracy than the one that relies exclusively on VGG16 to extract bottleneck features. This strategy could cut the time it takes for the network to learn and improve its ability to classify things. The experiment shows that the method works by using data from OASIS. A typical transfer learning network's classification accuracy is about 8% better with this method than with a typical network, and it takes about 1/60 of the time with this method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.